JASPER’S MARKET SQUAWK 08-02-2023 JP Hawkish But Not Enough Once again, Fed Chair J. Powell made his first appearance since last week’s hot jobs report but noted nothing new compared to the post-FOMC presser. Markets reacted to different comments for somewhat choppy trading, with risk appetite rising on Powell’s relatively conservative stance. Key Factors for…
Iress partners Centroid Solutions to power pricing and trading data APIs Enhancing Pricing and Trading Solutions Centroid is now able to offer its clients a more robust solution for pricing and trading exchange traded products, thanks to the integration of Iress’s ConsolidatedFEED API data solution. Iress’s API data and trading solutions have been seamlessly incorporated…
SOTERA HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $10… New Orleans, Feb. 07, 2023 (GLOBE NEWSWIRE) Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until
Mission Produce Establishes Vertical Integration in South Africa Partnership with ZZ2, Cap, and Core Fruit On February 7, 2023, Mission Produce, Inc. announced their partnership with ZZ2, Criterion Africa Partners (Cap), and Core Fruit to develop over 1,000 hectares of avocados for global distribution. This strategic move is set to establish vertical integration in South…
Breaking News: Cellectis Successfully Completes Global Offering and Underwriters Exercise Option to Purchase Additional Shares Description: NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today: the…
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer Biologics expert and long-time veteran of Johnson & Johnson will be responsible for the strategic development of Larimar’s clinical and R&D programs BALA CYNWYD, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments…
PLDT Inc. Investor Alert: An Inside Look at the Class Action Lawsuit The Investigation On February 7, 2023, Kaplan Fox & Kilsheimer LLP announced that they are currently investigating claims on behalf of investors of PLDT Inc. This investigation comes in response to a complaint filed on behalf of investors who purchased or acquired PLDT…
Join Us for a Fun and Quirky Interview with HeartSciences CEO on The Big Biz Show – February 7 at 11:45 AM Pacific Time! Description: Southlake, Texas, Feb. 07, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by…
